Aridis Pharmaceuticals In... (ARDS)
OTC: ARDS
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 01, 2025, 9:51 AM
Aridis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | FY 2022 | FY 2021 |
Period Ending | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a |
Cost of Revenue | n/a | n/a |
Gross Profit | n/a | n/a |
Operating Income | -29.99M | -43.71M |
Interest Income | n/a | n/a |
Pretax Income | -30.37M | -43.19M |
Net Income | -30.75M | -42.28M |
Selling & General & Admin | 7.16M | 7.31M |
Research & Development | 25.92M | 37.94M |
Other Expenses | -3.09M | -1.53M |
Operating Expenses | 29.99M | 43.71M |
Interest Expense | 378K | -245K |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 29.99M | 43.71M |
Income Tax Expense | 378K | -912K |
Shares Outstanding (Basic) | 18.78M | 12.29M |
Shares Outstanding (Diluted) | 18.78M | 12.29M |
EPS (Basic) | -1.64 | -3.44 |
EPS (Diluted) | -1.64 | -3.44 |
EBITDA | -29.51M | -44.43M |
EBIT | n/a | -43.44M |
Depreciation & Amortization | 487K | -722K |
Source: Financial Modeling Prep. Financial Sources.